ClinicalTrials.gg
CompletedNCT03546153Updated Sep 27, 2019

Examining Effects of Aerobic Exercise on Pain Sensation

An interventional study of Aerobic exercise program in Chronic Low Back Pain, sponsored by University of Kansas Medical Center. Completed at 1 site in United States. Open to participants aged 21 Years to 70 Years. Per ClinicalTrials.gov, last updated 2019-09-27.

Sponsored by University of Kansas Medical Center · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Not applicable
Ages
21 Years to 70 Years
Sex
All
01

Study summary

By doing this study, researchers hope to learn effects of aerobic exercise on over activated nervous system in people with chronic low back pain.

Read the detailed description

Chronic low back pain is a common condition in the world. About 85% of people with low back pain do not know the cause of their pain. This leads to ineffective treatments.

Recently, the idea of an over activated nervous system is thought to be one of the main reasons for chronic pain. Over activated nervous system means pain processing areas in the spine or brain might be more sensitive. Aerobic exercise, such as walking and cycling, is often used to decrease chronic pain. Aerobic exercise is a form of physical exercise that strengthen the heart and lungs in order to improve the body's utilization of oxygen.

The researchers want to examine if aerobic exercise is effective in decreasing over activation of the nervous system. Gaining a better understanding of effects of aerobic exercise on the nervous system may lead to more effective treatments for low back pain.

02

Conditions studied

  • Chronic Low Back Pain
03

In context

Lead sponsor

University of Kansas Medical Center is the lead sponsor of 492 studies on the registry; 113 are open to participants now.

Of its 38 completed or terminated interventional studies of FDA-regulated products, 24 (63%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Lower back pain (LBP) for more than 3 months
  • A minimal pain level of 3 on the 0-10 pain numerical rating scale (NRS) in the last 7 days
  • Can read and understand English.

Exclusion criteria

Exclusion Criteria:

  • Nerve root compression that resulted in numbness or decrease in sensation in the areas for the pain sensitivity tests as reported by the subject
  • cervical or thoracic pain as a main complaint
  • spinal pathologies such as fracture, tumor, infection, and severe inflammation
  • severe spinal deformity
  • severe cardiovascular and neurological diseases
  • cancer
  • history of spinal surgery
  • currently seeking active treatments for LBP other than medications
  • resting blood pressure more than 160/90 mmHg 49
  • currently taking blood thinning medications
  • uncontrolled diabetes
  • cannot have blood pressure taken
  • participated in a similar trial in the past
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
10 participants (actual)

Study arms

  • Experimental
    Aerobic exercise program

    Participants will complete 12 week exercise program.

    Behavioral: Aerobic exercise program

Interventions

  • BehavioralAerobic exercise program

    Exercise program consists of training for 60 minutes, three times per week for 12 weeks. Participants will use a treadmill, Nu stepper/bike or elliptical to exercise.

06

What researchers measure

Primary outcomes

  1. Pain sensitivity (Pressure pain threshold)

    Sensitivity will be measured using a pressure algometer.

    Time frame: Change from Baseline (pre-treatment) to after completion of 3 months of aerobic exercise training (post-treatment)

  2. 2011 FM survey

    Sensitivity will be measured using the 2011 Fibromyalgia (FM) Survey Criteria. The survey includes widespread pain index and symptom severity scale. The total score is 31 and scores more than 13 is considered fibromyalgia positive, suggesting presence of central sensitization.

    Time frame: Change from Baseline (pre-treatment) to after completion of 3 months of aerobic exercise training (post-treatment)

  3. Opioid consumption

    Use of opioids (dose, frequency, and duration) will be obtained by interviewing the subjects

    Time frame: Change from Baseline (pre-treatment) to after completion of 3 months of aerobic exercise training (post-treatment)

  4. Oswestry Disability Index

    This questionnaire consists of questions related to daily functions and degrees to which back pain interferes with these functions. Each items is measured on a 6-point scale with a total possible score of 50. Higher numbers indicate greater disability.

    Time frame: Change from Baseline (pre-treatment) to after completion of 3 months of aerobic exercise training (post-treatment)

Secondary outcomes

  1. Pain Sensitivity (CPM test)

    Measure of the functionality of descending inhibitory pain pathways with use of pressure algometry.

    Time frame: Change from Baseline (pre-treatment) to after completion of 3 months of aerobic exercise training (post-treatment)

  2. Fear Avoidance Belief Questionnaire

    The survey has items related to fear about physical and work activities. Each item is scored from 0-6 points, with higher number indicating increased fear of activity or work.

    Time frame: Change from Baseline (pre-treatment) to after completion of 3 months of aerobic exercise training (post-treatment)

  3. Pain Catastrophizing Scale

    PCS is a validated 13--item scale with questions related to catastrophizing behavior. Total score is 52 with higher scores indicating greater catastrophic thoughts.

    Time frame: Change from Baseline (pre-treatment) to after completion of 3 months of aerobic exercise training (post-treatment)

  4. Beck Depression Inventory

    Beck depression questionnaire contains 21 multiple-choice depression related questions on a scale value of 0 to 3. Higher scores indicate greater depressive symptoms.

    Time frame: Change from Baseline (pre-treatment) to after completion of 3 months of aerobic exercise training (post-treatment)

  5. Beck Anxiety Inventory

    Beck anxiety questionnaire contains 21 multiple-choice questions, each score 0 (not al all) to 3 (severely). Higher scores indicate greater anxiety symptoms.

    Time frame: Change from Baseline (pre-treatment) to after completion of 3 months of aerobic exercise training (post-treatment)

  6. Pittsburgh Sleep Quality Index

    Pittsburgh sleep quality index contains 19 questions, creating 7 components that produce one global score. Higher scores indicate poorer sleep quality.

    Time frame: Change from Baseline (pre-treatment) to after completion of 3 months of aerobic exercise training (post-treatment)

  7. Lumbar spine range of motion

    Lumbar spine range of motion into forward, backward, and side bending will be assessed with two inclinometers or a tape measure. subjects will

    Time frame: Change from Baseline (pre-treatment) to after completion of 3 months of aerobic exercise training (post-treatment)

07

Study locations

1 site
  • University of Kansas Medical Center
    Kansas City, Kansas 66160, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 27, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03546153
Responsible party
Sponsor
First posted
Jun 6, 2018
Start date
Jun 1, 2018
Primary completion
Sep 1, 2019
Completion
Sep 1, 2019
Last update
Sep 27, 2019

Study contacts

Neena Sharma, PT, PhD, CMPT
principal investigator · University of Kansas Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion